Highly active antiretroviral therapy for HIV infection: lessons for the future

Abstract

HIV-related morbidity and mortality has been greatly reduced since the introduction of highly active antiretroviral therapy. Issues regarding the patient, the virus, the drugs and the treatment team are discussed. HIV treatment remains complex with a rapidly changing field of possibilities and views, and should therefore be limited to specialised centres.